Congress and the Administration Must Act on Solutions that Have Won Bipartisan Support to Deliver Relief for American Patients and Consumers For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today on the reintroduction of the Elijah E. Cummings Lower Drug Costs Now Act […]
Lawmakers Pass Pair of Bills Aimed at Boosting Generic and Biosimilar Competition For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Thursday applauding the passage of the Ensuring Innovation Act and the Advancing Education on Biosimilars Act of 2021 in the U.S. House of […]
Campaign Will Highlight Impact of Out-of-Control Drug Prices, Especially in Areas like Oncology, and the Urgency to Hold Big Pharma Accountable For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) launched a campaign Tuesday encouraging policymakers to act on campaign promises to hold Big Pharma accountable […]
Government Report Finds No Relationship Between Drug Company R&D and Prescription Drug Prices For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Friday responding to a new report from the Congressional Budget Office (CBO) titled “Research and Development in the Pharmaceutical Industry,” which […]
Legislation Will Boost Transparency to Hold Big Pharma Accountable for Egregious Pricing Practices For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement today applauding the reintroduction of The Fair Accountability and Innovative Research (FAIR) Drug Pricing Act in the U.S. Senate. “Greater list price […]
Lawmakers on HELP Subcommittee Can Add to Bipartisan Momentum to Hold Big Pharma Accountable For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement today ahead of a hearing on prescription drug prices scheduled for Tuesday before the U.S. Senate Committee on Health, Education, Labor […]
Campaign Looks Forward to Working with Secretary Becerra to Lower Drug Prices and Hold Big Pharma Accountable For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement today after the United States Senate voted to confirm Xavier Becerra as the next Secretary of the U.S. […]
Big Pharma CFO Hypes “Significant Opportunity” From “Pricing Perspective” Post-Pandemic For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement today reacting to the latest comments from Pfizer Chief Financial Officer Frank D’Amelio hyping the company’s “significant opportunity” to hike vaccine prices to boost profits post-pandemic. […]
Big Pharma Has Already Repeatedly Hiked Drug Prices During Public Health Crisis, Now Drug Companies Are Eyeing Chance to Price-Gouge Vaccines For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement today reacting to comments from Pfizer Chief Financial Officer Frank D’Amelio promising to […]
Resource Provides Information on Out-of-Control Drug Prices — Outlines Bipartisan, Market-Based Solutions to Hold Big Pharma Accountable and Deliver Relief for American Patients For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a briefing packet Monday for Members of Congress that aims to provide lawmakers, […]